▶ 調査レポート

世界のレジオネラ症検査市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Legionnaire Disease Testing Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のレジオネラ症検査市場規模・現状・予測(2021年-2027年) / Global Legionnaire Disease Testing Market Size, Status and Forecast 2021-2027 / QFJ1-4420資料のイメージです。• レポートコード:QFJ1-4420
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、レジオネラ症検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(尿中抗原検査、直接蛍光抗体(DFA)染色、複合検査(培養・尿中抗原検査)、その他)、用途別市場規模(病院、診断研究所、研究センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・レジオネラ症検査の市場動向
・企業の競争状況、市場シェア
・レジオネラ症検査の種類別市場規模と予測2016-2027(尿中抗原検査、直接蛍光抗体(DFA)染色、複合検査(培養・尿中抗原検査)、その他)
・レジオネラ症検査の用途別市場規模と予測2016-2027(病院、診断研究所、研究センター、その他)
・レジオネラ症検査の北米市場規模2016-2027(アメリカ、カナダ)
・レジオネラ症検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・レジオネラ症検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・レジオネラ症検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・レジオネラ症検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Danaher、Bio-Rad、Abbott、Roche、Thermo Fischer Scientific、BD、Aquacert、BioMérieux、Idexx、Albagaia)
・結論

Legionnaires disease is atypical pneumonia caused by legionella bacteria.

Market Analysis and Insights: Global Legionnaire Disease Testing Market
The global Legionnaire Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Legionnaire Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Legionnaire Disease Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Legionnaire Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Legionnaire Disease Testing market.

Global Legionnaire Disease Testing Scope and Market Size
Legionnaire Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Legionnaire Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Urinary Antigen Testing
Direct Fluorescent Antibody (DFA) Stain
Combination Testing (Culture and Urinary Antigen Testing)
Others

Segment by Application
Hospitals
Diagnostic Laboratories
Research Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Danaher
Bio-Rad
Abbott
Roche
Thermo Fischer Scientific
BD
Aquacert
BioMérieux
Idexx
Albagaia

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Legionnaire Disease Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urinary Antigen Testing
1.2.3 Direct Fluorescent Antibody (DFA) Stain
1.2.4 Combination Testing (Culture and Urinary Antigen Testing)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Legionnaire Disease Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Legionnaire Disease Testing Market Perspective (2016-2027)
2.2 Legionnaire Disease Testing Growth Trends by Regions
2.2.1 Legionnaire Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Legionnaire Disease Testing Historic Market Share by Regions (2016-2021)
2.2.3 Legionnaire Disease Testing Forecasted Market Size by Regions (2022-2027)
2.3 Legionnaire Disease Testing Industry Dynamic
2.3.1 Legionnaire Disease Testing Market Trends
2.3.2 Legionnaire Disease Testing Market Drivers
2.3.3 Legionnaire Disease Testing Market Challenges
2.3.4 Legionnaire Disease Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Legionnaire Disease Testing Players by Revenue
3.1.1 Global Top Legionnaire Disease Testing Players by Revenue (2016-2021)
3.1.2 Global Legionnaire Disease Testing Revenue Market Share by Players (2016-2021)
3.2 Global Legionnaire Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Legionnaire Disease Testing Revenue
3.4 Global Legionnaire Disease Testing Market Concentration Ratio
3.4.1 Global Legionnaire Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Legionnaire Disease Testing Revenue in 2020
3.5 Legionnaire Disease Testing Key Players Head office and Area Served
3.6 Key Players Legionnaire Disease Testing Product Solution and Service
3.7 Date of Enter into Legionnaire Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Legionnaire Disease Testing Breakdown Data by Type
4.1 Global Legionnaire Disease Testing Historic Market Size by Type (2016-2021)
4.2 Global Legionnaire Disease Testing Forecasted Market Size by Type (2022-2027)

5 Legionnaire Disease Testing Breakdown Data by Application
5.1 Global Legionnaire Disease Testing Historic Market Size by Application (2016-2021)
5.2 Global Legionnaire Disease Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Legionnaire Disease Testing Market Size (2016-2027)
6.2 North America Legionnaire Disease Testing Market Size by Type
6.2.1 North America Legionnaire Disease Testing Market Size by Type (2016-2021)
6.2.2 North America Legionnaire Disease Testing Market Size by Type (2022-2027)
6.2.3 North America Legionnaire Disease Testing Market Size by Type (2016-2027)
6.3 North America Legionnaire Disease Testing Market Size by Application
6.3.1 North America Legionnaire Disease Testing Market Size by Application (2016-2021)
6.3.2 North America Legionnaire Disease Testing Market Size by Application (2022-2027)
6.3.3 North America Legionnaire Disease Testing Market Size by Application (2016-2027)
6.4 North America Legionnaire Disease Testing Market Size by Country
6.4.1 North America Legionnaire Disease Testing Market Size by Country (2016-2021)
6.4.2 North America Legionnaire Disease Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Legionnaire Disease Testing Market Size (2016-2027)
7.2 Europe Legionnaire Disease Testing Market Size by Type
7.2.1 Europe Legionnaire Disease Testing Market Size by Type (2016-2021)
7.2.2 Europe Legionnaire Disease Testing Market Size by Type (2022-2027)
7.2.3 Europe Legionnaire Disease Testing Market Size by Type (2016-2027)
7.3 Europe Legionnaire Disease Testing Market Size by Application
7.3.1 Europe Legionnaire Disease Testing Market Size by Application (2016-2021)
7.3.2 Europe Legionnaire Disease Testing Market Size by Application (2022-2027)
7.3.3 Europe Legionnaire Disease Testing Market Size by Application (2016-2027)
7.4 Europe Legionnaire Disease Testing Market Size by Country
7.4.1 Europe Legionnaire Disease Testing Market Size by Country (2016-2021)
7.4.2 Europe Legionnaire Disease Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Legionnaire Disease Testing Market Size (2016-2027)
8.2 Asia-Pacific Legionnaire Disease Testing Market Size by Type
8.2.1 Asia-Pacific Legionnaire Disease Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Legionnaire Disease Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Legionnaire Disease Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Legionnaire Disease Testing Market Size by Application
8.3.1 Asia-Pacific Legionnaire Disease Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Legionnaire Disease Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Legionnaire Disease Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Legionnaire Disease Testing Market Size by Region
8.4.1 Asia-Pacific Legionnaire Disease Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Legionnaire Disease Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Legionnaire Disease Testing Market Size (2016-2027)
9.2 Latin America Legionnaire Disease Testing Market Size by Type
9.2.1 Latin America Legionnaire Disease Testing Market Size by Type (2016-2021)
9.2.2 Latin America Legionnaire Disease Testing Market Size by Type (2022-2027)
9.2.3 Latin America Legionnaire Disease Testing Market Size by Type (2016-2027)
9.3 Latin America Legionnaire Disease Testing Market Size by Application
9.3.1 Latin America Legionnaire Disease Testing Market Size by Application (2016-2021)
9.3.2 Latin America Legionnaire Disease Testing Market Size by Application (2022-2027)
9.3.3 Latin America Legionnaire Disease Testing Market Size by Application (2016-2027)
9.4 Latin America Legionnaire Disease Testing Market Size by Country
9.4.1 Latin America Legionnaire Disease Testing Market Size by Country (2016-2021)
9.4.2 Latin America Legionnaire Disease Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Legionnaire Disease Testing Market Size (2016-2027)
10.2 Middle East & Africa Legionnaire Disease Testing Market Size by Type
10.2.1 Middle East & Africa Legionnaire Disease Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Legionnaire Disease Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Legionnaire Disease Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Legionnaire Disease Testing Market Size by Application
10.3.1 Middle East & Africa Legionnaire Disease Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Legionnaire Disease Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Legionnaire Disease Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Legionnaire Disease Testing Market Size by Country
10.4.1 Middle East & Africa Legionnaire Disease Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Legionnaire Disease Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Legionnaire Disease Testing Introduction
11.1.4 Danaher Revenue in Legionnaire Disease Testing Business (2016-2021)
11.1.5 Danaher Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Legionnaire Disease Testing Introduction
11.2.4 Bio-Rad Revenue in Legionnaire Disease Testing Business (2016-2021)
11.2.5 Bio-Rad Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Legionnaire Disease Testing Introduction
11.3.4 Abbott Revenue in Legionnaire Disease Testing Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Legionnaire Disease Testing Introduction
11.4.4 Roche Revenue in Legionnaire Disease Testing Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Thermo Fischer Scientific
11.5.1 Thermo Fischer Scientific Company Details
11.5.2 Thermo Fischer Scientific Business Overview
11.5.3 Thermo Fischer Scientific Legionnaire Disease Testing Introduction
11.5.4 Thermo Fischer Scientific Revenue in Legionnaire Disease Testing Business (2016-2021)
11.5.5 Thermo Fischer Scientific Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Legionnaire Disease Testing Introduction
11.6.4 BD Revenue in Legionnaire Disease Testing Business (2016-2021)
11.6.5 BD Recent Development
11.7 Aquacert
11.7.1 Aquacert Company Details
11.7.2 Aquacert Business Overview
11.7.3 Aquacert Legionnaire Disease Testing Introduction
11.7.4 Aquacert Revenue in Legionnaire Disease Testing Business (2016-2021)
11.7.5 Aquacert Recent Development
11.8 BioMérieux
11.8.1 BioMérieux Company Details
11.8.2 BioMérieux Business Overview
11.8.3 BioMérieux Legionnaire Disease Testing Introduction
11.8.4 BioMérieux Revenue in Legionnaire Disease Testing Business (2016-2021)
11.8.5 BioMérieux Recent Development
11.9 Idexx
11.9.1 Idexx Company Details
11.9.2 Idexx Business Overview
11.9.3 Idexx Legionnaire Disease Testing Introduction
11.9.4 Idexx Revenue in Legionnaire Disease Testing Business (2016-2021)
11.9.5 Idexx Recent Development
11.10 Albagaia
11.10.1 Albagaia Company Details
11.10.2 Albagaia Business Overview
11.10.3 Albagaia Legionnaire Disease Testing Introduction
11.10.4 Albagaia Revenue in Legionnaire Disease Testing Business (2016-2021)
11.10.5 Albagaia Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Legionnaire Disease Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Urinary Antigen Testing
Table 3. Key Players of Direct Fluorescent Antibody (DFA) Stain
Table 4. Key Players of Combination Testing (Culture and Urinary Antigen Testing)
Table 5. Key Players of Others
Table 6. Global Legionnaire Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Legionnaire Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Legionnaire Disease Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Legionnaire Disease Testing Market Share by Regions (2016-2021)
Table 10. Global Legionnaire Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Legionnaire Disease Testing Market Share by Regions (2022-2027)
Table 12. Legionnaire Disease Testing Market Trends
Table 13. Legionnaire Disease Testing Market Drivers
Table 14. Legionnaire Disease Testing Market Challenges
Table 15. Legionnaire Disease Testing Market Restraints
Table 16. Global Legionnaire Disease Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Legionnaire Disease Testing Market Share by Players (2016-2021)
Table 18. Global Top Legionnaire Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Legionnaire Disease Testing as of 2020)
Table 19. Ranking of Global Top Legionnaire Disease Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Legionnaire Disease Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Legionnaire Disease Testing Product Solution and Service
Table 23. Date of Enter into Legionnaire Disease Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Legionnaire Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Legionnaire Disease Testing Revenue Market Share by Type (2016-2021)
Table 27. Global Legionnaire Disease Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Legionnaire Disease Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Legionnaire Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Legionnaire Disease Testing Revenue Market Share by Application (2016-2021)
Table 31. Global Legionnaire Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Legionnaire Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Legionnaire Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Legionnaire Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Legionnaire Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Legionnaire Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Legionnaire Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Legionnaire Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Legionnaire Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Legionnaire Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Legionnaire Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Legionnaire Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Legionnaire Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Legionnaire Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Legionnaire Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Legionnaire Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Legionnaire Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Legionnaire Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Legionnaire Disease Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Legionnaire Disease Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Legionnaire Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Legionnaire Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Legionnaire Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Legionnaire Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Legionnaire Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Legionnaire Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Legionnaire Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Legionnaire Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Legionnaire Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Legionnaire Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Legionnaire Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Legionnaire Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. Danaher Company Details
Table 64. Danaher Business Overview
Table 65. Danaher Legionnaire Disease Testing Product
Table 66. Danaher Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 67. Danaher Recent Development
Table 68. Bio-Rad Company Details
Table 69. Bio-Rad Business Overview
Table 70. Bio-Rad Legionnaire Disease Testing Product
Table 71. Bio-Rad Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 72. Bio-Rad Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Legionnaire Disease Testing Product
Table 76. Abbott Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Legionnaire Disease Testing Product
Table 81. Roche Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Thermo Fischer Scientific Company Details
Table 84. Thermo Fischer Scientific Business Overview
Table 85. Thermo Fischer Scientific Legionnaire Disease Testing Product
Table 86. Thermo Fischer Scientific Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 87. Thermo Fischer Scientific Recent Development
Table 88. BD Company Details
Table 89. BD Business Overview
Table 90. BD Legionnaire Disease Testing Product
Table 91. BD Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 92. BD Recent Development
Table 93. Aquacert Company Details
Table 94. Aquacert Business Overview
Table 95. Aquacert Legionnaire Disease Testing Product
Table 96. Aquacert Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 97. Aquacert Recent Development
Table 98. BioMérieux Company Details
Table 99. BioMérieux Business Overview
Table 100. BioMérieux Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 101. BioMérieux Recent Development
Table 102. Idexx Company Details
Table 103. Idexx Business Overview
Table 104. Idexx Legionnaire Disease Testing Product
Table 105. Idexx Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 106. Idexx Recent Development
Table 107. Albagaia Company Details
Table 108. Albagaia Business Overview
Table 109. Albagaia Legionnaire Disease Testing Product
Table 110. Albagaia Revenue in Legionnaire Disease Testing Business (2016-2021) & (US$ Million)
Table 111. Albagaia Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Legionnaire Disease Testing Market Share by Type: 2020 VS 2027
Figure 2. Urinary Antigen Testing Features
Figure 3. Direct Fluorescent Antibody (DFA) Stain Features
Figure 4. Combination Testing (Culture and Urinary Antigen Testing) Features
Figure 5. Others Features
Figure 6. Global Legionnaire Disease Testing Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Research Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Legionnaire Disease Testing Report Years Considered
Figure 12. Global Legionnaire Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Legionnaire Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Legionnaire Disease Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global Legionnaire Disease Testing Market Share by Regions (2022-2027)
Figure 16. Global Legionnaire Disease Testing Market Share by Players in 2020
Figure 17. Global Top Legionnaire Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Legionnaire Disease Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Legionnaire Disease Testing Revenue in 2020
Figure 19. Global Legionnaire Disease Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global Legionnaire Disease Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Legionnaire Disease Testing Market Share by Type (2016-2027)
Figure 23. North America Legionnaire Disease Testing Market Share by Application (2016-2027)
Figure 24. North America Legionnaire Disease Testing Market Share by Country (2016-2027)
Figure 25. United States Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Legionnaire Disease Testing Market Share by Type (2016-2027)
Figure 29. Europe Legionnaire Disease Testing Market Share by Application (2016-2027)
Figure 30. Europe Legionnaire Disease Testing Market Share by Country (2016-2027)
Figure 31. Germany Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Legionnaire Disease Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Legionnaire Disease Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Legionnaire Disease Testing Market Share by Region (2016-2027)
Figure 41. China Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Legionnaire Disease Testing Market Share by Type (2016-2027)
Figure 49. Latin America Legionnaire Disease Testing Market Share by Application (2016-2027)
Figure 50. Latin America Legionnaire Disease Testing Market Share by Country (2016-2027)
Figure 51. Mexico Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Legionnaire Disease Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Legionnaire Disease Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Legionnaire Disease Testing Market Share by Country (2016-2027)
Figure 57. Turkey Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Legionnaire Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Danaher Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 61. Bio-Rad Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 64. Thermo Fischer Scientific Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 65. BD Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 66. Aquacert Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 67. BioMérieux Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 68. Idexx Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 69. Albagaia Revenue Growth Rate in Legionnaire Disease Testing Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed